Trial
NCT03473340
Studying the Treatment Effect of Pirfenidone in Chronic Lung Allograft Dysfunction (STOP-CLAD)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Michigan
Collaborators
Genentech, Inc.
Condition
Disorder Related to Lung Transplantation
Intervention
Pirfenidone Capsule
Why stopped
Slow and delayed recruitment due in part to COVID, led to a decision to end funding and terminate the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-17